Matthew D Ringel MD

Matthew D Ringel MD
ProfessorCollege of
445D McCampbell Hall 1581 Dodd Drive Columbus Ohio 43210
Phone:614-292-3800Fax: 614-247-1622
  • Molecular Biology and Cancer Genetics
  • Administrative

Current Publications

  • Jhiang SMApigenin in Combination with Akt Inhibition Significantly Enhances Thyrotropin-Stimulated Radioiodide Accumulation in Thyroid Cells.Thyroid 3/6/2014
  • Kirschner LSFollicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid specific deletion of Prkar1a and Pten in mice.J Clin Endocrinol Metab jc20133101 2/10/2014
  • Vaccaro PSSDHB Gene Mutation in a Carotid Body Paraganglioma: Case Report and Review of the Paraganglioma Syndromes.Ann Vasc Surg 2/5/2014
  • Yusof AM, Kothandaraman S, Zhang X, Saji M, Ringel MD, Tweedle MF, Phay JEDevelopment of a calcium-sensing receptor molecular imaging agent.Surgery 154 1378-84; discussion 1384 12/1/2013
  • Ding H, Yusof AM, Kothandaraman S, Saji M, Wang C, Kumar K, Milum K, Carleton M, Pan X, Ringel MD, Tweedle MF, Phay JELocalization of CaSR antagonists in CaSR-expressing medullary thyroid cancer.J Clin Endocrinol Metab 98 E1722-9 11/1/2013
  • Liyanarachchi S, Wojcicka A, Li W, Czetwertynska M, Stachlewska E, Nagy R, Hoag K, Wen B, Ploski R, Ringel MD, Kozłowicz-Gudzinska I, Gierlikowski W, Jazdzewski K, He H, de la Chapelle ACumulative Risk Impact of Five Genetic Variants Associated with Papillary Thyroid Carcinoma.Thyroid in press 8/29/2013
  • Ma Y, McCarty SK, Kapuriya NP, Brendel VJ, Wang C, Zhang X, Jarjoura D, Saji M, Chen CS, Ringel MDDevelopment of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration.J Clin Endocrinol Metab 98(8) E1314-22 8/1/2013
  • Ringel MD, Nabhan FApproach to follow-up of the patient with differentiated thyroid cancer and positive anti-thyroglobulin antibodies.J Clin Endocrinol Metab 98(8) 3104-10 8/1/2013
  • He H, Bronisz A, Liyanarachchi S, Nagy R, Li W, Huang Y, Akagi K, Saji M, Kula D, Wojcicka A, Sebastian N, Wen B, Puch Z, Kalemba M, Stachlewska E, Czetwertynska M, Dlugosinska J, Dymecka K, Ploski R, Krawczyk M, Morrison PJ, Ringel MD, Kloos RT, Jazdzewski K, Symer DE, Vieland VJ, Ostrowski M, Jarzab B, de la Chapelle ASRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.J Clin Endocrinol Metab 98(5) E973-80 5/1/2013
  • Kloos RT, Valle LA, Sipos JA, Porter K, Ringel MD, Khawaja R, Gorodeski Baskin RLIn thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 μU/mL after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin.Thyroid 23(2) 185-93 2/1/2013
  • Phay J, Ringel MDMetastatic mechanisms in follicular cell-derived thyroid cancer.Endocr Relat Cancer 20(6) R307-19 1/1/2013
  • He X, Saji M, Radhakrishnan D, Romigh T, Ngeow J, Yu Q, Wang Y, Ringel MD, Eng CPTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.J Clin Endocrinol Metab 97(11) E2179-87 11/1/2012
  • Liu YY, Zhang X, Ringel MD, Jhiang SModulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells.Endocr Relat Cancer 19(3) 291-304 6/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: